Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 20, 2022
Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agentsNobuhiro Hattori, Hiroki Ikeda, Tsunamasa Watanabe, et al.
Plos One|March 19, 2016
Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1bNobuyuki Matsumoto, Hiroki Ikeda, Ryuta Shigefuku, et al.
Cancer Science|April 19, 2017
Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinomaHirofumi Kiyokawa, Hiroshi Yasuda, Ritsuko Oikawa, et al.
Plos One|February 24, 2015
Influence of genes suppressing interferon effects in peripheral blood mononuclear cells during triple antiviral therapy for chronic hepatitis CSayuki Iijima, Kentaro Matsuura, Tsunamasa Watanabe, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Daclatasvir and asunaprevir improves health-related quality of life in Japanese patients infected with hepatitis C virusHiroki Ikeda, Tsunamasa Watanabe, Nobuyuki Matsumoto, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
Comparative study between sorafenib and lenvatinib as the first-line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real-world settingTaito Fukushima, Manabu Morimoto, Makoto Ueno, et al.
The Oncologist|April 6, 2023
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabTaito Fukushima, Manabu Morimoto, Satoshi Kobayashi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2024
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinomaSatoshi Kobayashi, Taito Fukushima, Makoto Ueno, et al.
BMC Cancer|May 7, 2022
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinomaSatoshi Kobayashi, Taito Fukushima, Makoto Ueno, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|March 26, 2016
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?Hiroki Ikeda, Chiaki Okuse, Tsunamasa Watanabe, et al.
Pageof 12